ALK-Abelló A/S
ALK-B
주식 순위
#2408
ALK-Abelló A/S is a global leader in allergy solutions, with operations... ALK-Abelló A/S is a global leader in allergy solutions, with operations spanning Europe, North America, and other international regions. The company offers a comprehensive portfolio of treatments for allergic rhinitis and allergic asthma, featuring key products such as GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDACURE, and ITULAZAX. ALK-Abelló specializes in allergy immunotherapy, providing options like injections, sublingual drops, and tablets to address a wide range of sensitivities, including those to grass, ragweed, house dust mites, Japanese cedar, various tree pollens, and certain foods. Furthermore, the company engages with consumers through a digital healthcare ecosystem, a platform designed to connect with allergy sufferers early in their journey, offering tools, e-commerce solutions, and guidance to support and streamline access to immunotherapy. ALK-Abelló also provides essential diagnostic allergy services, including skin prick and blood tests, alongside emergency treatments such as intramuscular adrenaline injections for severe, life-threatening allergic reactions like anaphylaxis. The company was established in 1923 and is based in Hørsholm, Denmark.
주가
$36.42
마지막 동기화: 2026-10-21
시가총액
$8.08B
변동 (1일)
-3.54%
변동 (1년)
12.58%
국가
DK
거래 ALK-Abelló A/S (ALK-B)
카테고리
Healthcare
ALK-Abelló A/S (ALK-B)의 주가 이력
최고 종가: $33.18 (2026-10-01 기준)
최저 종가: $4.68 (2009-11-01 기준)
최저 종가: $4.68 (2009-11-01 기준)
ALK-Abelló A/S의 주가 이력 (2009 ~ 2026)
연간 주가 성과
| 연도 | 성과 |
|---|---|
| 2026 (TTM) | -0.99% |
| 2025 | 62.35% |
| 2024 | 75.96% |
| 2023 | -10.08% |
| 2022 | -41.52% |
| 2021 | 84.43% |
| 2020 | 3.84% |
| 2019 | 35.14% |
| 2018 | 16.65% |
| 2017 | 25.63% |
| 2016 | 3.30% |
| 2015 | 10.00% |
| 2014 | 7.87% |
| 2013 | 53.73% |
| 2012 | 15.92% |
| 2011 | -22.10% |
| 2010 | -20.73% |
| 2009 | 0.00% |
유사 기업 또는 경쟁사의 주가
| 회사 | 주가 | 변동률 1년% | 국가 |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.27 | -4.17% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $752.87 | 7.01% |
CH
|
